Axa’s American Renal Associates Holdings, Inc ARA Stock Holding History

Axa’s Portfolio ARA Stock Details ARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-12,000	Closed	-$189K	–	1415
2018 Q2	$189K	Buy	+12,000	New	+$189K	﹤0.01%	1307

Other funds holding ARA

Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

WIC

Whitegate Investment Counselors Concord, New Hampshire $315M AUM 10.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Axa's ARA Position: Q3 2018 in Review

Axa sold out of American Renal Associates Holdings, Inc (ARA) in Q3 2018, closing a stake of 12,000 shares — an estimated $189K sold.

Axa first reported a position in ARA in Q2 2018 and held it in 1 quarter. The position peaked at $189K in Q2 2018. 82 funds tracked by Wall St. Rank hold ARA as of Q3 2018.

Axa reported no remaining American Renal Associates Holdings, Inc position as of Q3 2018 after selling out during the quarter.
Axa sold 12,000 American Renal Associates Holdings, Inc shares in Q3 2018, an estimated $189K.
Axa first reported a position in American Renal Associates Holdings, Inc in Q2 2018 and held it in 1 quarter.
Axa's American Renal Associates Holdings, Inc position peaked at $189K in Q2 2018.
82 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q3 2018.

Based on Axa's 13F filing for Q3 2018, filed 8 Nov 2018.